Chinese General Practice ›› 2023, Vol. 26 ›› Issue (30): 3791-3796.DOI: 10.12114/j.issn.1007-9572.2023.0198
Special Issue: 心力衰竭最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-02-27
Revised:
2023-05-15
Published:
2023-10-20
Online:
2023-05-31
Contact:
REN Fuxian, GAO Dengfeng
通讯作者:
任付先, 高登峰
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0198
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | 住院时间〔M(P25,P75),d〕 | 感染〔例(%)〕 | 糖尿病〔例(%)〕 | 高血压〔例(%)〕 | 慢性阻塞性肺疾病〔例(%)〕 | |
---|---|---|---|---|---|---|---|---|---|
生存组 | 564 | 72.9(64.9,80.5) | 317/247 | 7(5,9) | 191(33.9) | 197(34.9) | 342(60.6) | 52(9.2) | |
死亡组 | 19 | 77.8(68.6,81.8) | 11/8 | 2(2,7) | 12(63.2) | 11(57.9) | 12(63.2) | 3(15.8) | |
Z(χ2)值 | -1.682 | 0.021a | -6.378 | 6.949a | 4.224a | 0.049a | 0.922a | ||
P值 | 0.092 | 0.884 | 0.059 | 0.008 | 0.040 | 0.825 | 0.337 | ||
组别 | 肺循环障碍〔例(%)〕 | 心律失常〔例(%)〕 | 瓣膜病〔例(%)〕 | 周围血管病〔例(%)〕 | 脑血管病〔例(%)〕 | 肾衰竭〔例(%)〕 | 肝病〔例(%)〕 | 肥胖症〔例(%)〕 | 风湿性心脏病〔例(%)〕 |
生存组 | 49(8.7) | 253(44.9) | 48 (8.5) | 56 (9.9) | 137(24.3) | 89(15.8) | 23(4.1) | 32(5.7) | 0 |
死亡组 | 9(47.4) | 7(36.8) | 2(10.5) | 5(26.3) | 9(47.4) | 9(47.4) | 0 | 1(5.3) | 8(42.1) |
Z(χ2)值 | 30.697a | 0.487a | 0.094a | 5.268a | 5.164a | 12.990a | 0.808a | 0.082a | 0.273a |
P值 | <0.001 | 0.485 | 0.760 | 0.022 | 0.023 | <0.001 | 0.369 | 0.775 | 0.601 |
组别 | 肺源性心脏病〔例(%)〕 | 冠心病〔例(%)〕 | 心率〔M(P25,P75),次/min〕 | 平均动脉压〔M(P25,P75),mmHg〕 | 呼吸频率〔M(P25,P75),次/min〕 | 体温〔M(P25,P75),℃〕 | |||
生存组 | 7(1.2) | 411(72.9) | 86(74,101) | 97(87,110) | 20.00(19.00,22.00) | 36.30(36.20,36.50) | |||
死亡组 | 0 | 12(63.2) | 101(95,104) | 106(81,114) | 20.00(20.00,23.50) | 36.20(36.10,36.85) | |||
Z(χ2)值 | 0.239a | 0.871a | -2.677 | -1.260 | -1.981 | -0.132 | |||
P值 | 0.625 | 0.351 | 0.007 | 0.208 | 0.048 | 0.895 | |||
组别 | 血红蛋白〔M(P25,P75),g/L〕 | 阴离子间隙〔M(P25,P75),mmol/L 〕 | 尿素氮〔M(P25,P75),mmol/L 〕 | 肌酐〔M(P25,P75),μmol/L〕 | 葡萄糖〔M(P25,P75),mmol/L〕 | 钠〔M(P25,P75),mmol/L〕 | |||
生存组 | 129.00(113.00,144.00) | 10.20(8.10,11.80) | 7.41(5.54,11.57) | 84.15 (65.50,122.60) | 6.77(5.28, 9.67) | 138.00(135.00,141.00) | |||
死亡组 | 98.00 (86.50,124.50) | 15.90(9.70,19.70) | 28.48(9.66,31.38) | 170.50(110.40,277.60) | 9.70(8.08,14.54) | 141.00(137.50,146.50) | |||
Z(χ2)值 | -3.262 | -3.752 | -4.258 | -3.437 | -1.404 | -1.073 | |||
P值 | 0.001 | <0.001 | <0.001 | 0.001 | 0.160 | 0.283 | |||
组别 | 钾〔M(P25,P75),mmol/L〕 | 凝血酶原时间〔M(P25,P75),s〕 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 单核细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | NMLR〔M(P25,P75)〕 | |||
生存组 | 3.95(3.57,4.52) | 13.00(11.90,14.30) | 5.52(4.11,7.95) | 0.40(0.37,0.57) | 1.18(0.79,1.66) | 5.00(3.23,8.72) | |||
死亡组 | 4.10(3.75,4.41) | 12.90(12.60,16.35) | 6.17(4.34,6.82) | 0.44(0.34,0.62) | 0.89(0.73,1.73) | 8.36(3.15,9.55) | |||
Z(χ2)值 | -0.933 | -1.641 | -2.860 | -1.369 | -2.005 | -3.089 | |||
P值 | 0.351 | 0.101 | 0.004 | <0.001 | 0.045 | 0.002 |
Table 1 Compararion of baseline characteristics between the two groups
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | 住院时间〔M(P25,P75),d〕 | 感染〔例(%)〕 | 糖尿病〔例(%)〕 | 高血压〔例(%)〕 | 慢性阻塞性肺疾病〔例(%)〕 | |
---|---|---|---|---|---|---|---|---|---|
生存组 | 564 | 72.9(64.9,80.5) | 317/247 | 7(5,9) | 191(33.9) | 197(34.9) | 342(60.6) | 52(9.2) | |
死亡组 | 19 | 77.8(68.6,81.8) | 11/8 | 2(2,7) | 12(63.2) | 11(57.9) | 12(63.2) | 3(15.8) | |
Z(χ2)值 | -1.682 | 0.021a | -6.378 | 6.949a | 4.224a | 0.049a | 0.922a | ||
P值 | 0.092 | 0.884 | 0.059 | 0.008 | 0.040 | 0.825 | 0.337 | ||
组别 | 肺循环障碍〔例(%)〕 | 心律失常〔例(%)〕 | 瓣膜病〔例(%)〕 | 周围血管病〔例(%)〕 | 脑血管病〔例(%)〕 | 肾衰竭〔例(%)〕 | 肝病〔例(%)〕 | 肥胖症〔例(%)〕 | 风湿性心脏病〔例(%)〕 |
生存组 | 49(8.7) | 253(44.9) | 48 (8.5) | 56 (9.9) | 137(24.3) | 89(15.8) | 23(4.1) | 32(5.7) | 0 |
死亡组 | 9(47.4) | 7(36.8) | 2(10.5) | 5(26.3) | 9(47.4) | 9(47.4) | 0 | 1(5.3) | 8(42.1) |
Z(χ2)值 | 30.697a | 0.487a | 0.094a | 5.268a | 5.164a | 12.990a | 0.808a | 0.082a | 0.273a |
P值 | <0.001 | 0.485 | 0.760 | 0.022 | 0.023 | <0.001 | 0.369 | 0.775 | 0.601 |
组别 | 肺源性心脏病〔例(%)〕 | 冠心病〔例(%)〕 | 心率〔M(P25,P75),次/min〕 | 平均动脉压〔M(P25,P75),mmHg〕 | 呼吸频率〔M(P25,P75),次/min〕 | 体温〔M(P25,P75),℃〕 | |||
生存组 | 7(1.2) | 411(72.9) | 86(74,101) | 97(87,110) | 20.00(19.00,22.00) | 36.30(36.20,36.50) | |||
死亡组 | 0 | 12(63.2) | 101(95,104) | 106(81,114) | 20.00(20.00,23.50) | 36.20(36.10,36.85) | |||
Z(χ2)值 | 0.239a | 0.871a | -2.677 | -1.260 | -1.981 | -0.132 | |||
P值 | 0.625 | 0.351 | 0.007 | 0.208 | 0.048 | 0.895 | |||
组别 | 血红蛋白〔M(P25,P75),g/L〕 | 阴离子间隙〔M(P25,P75),mmol/L 〕 | 尿素氮〔M(P25,P75),mmol/L 〕 | 肌酐〔M(P25,P75),μmol/L〕 | 葡萄糖〔M(P25,P75),mmol/L〕 | 钠〔M(P25,P75),mmol/L〕 | |||
生存组 | 129.00(113.00,144.00) | 10.20(8.10,11.80) | 7.41(5.54,11.57) | 84.15 (65.50,122.60) | 6.77(5.28, 9.67) | 138.00(135.00,141.00) | |||
死亡组 | 98.00 (86.50,124.50) | 15.90(9.70,19.70) | 28.48(9.66,31.38) | 170.50(110.40,277.60) | 9.70(8.08,14.54) | 141.00(137.50,146.50) | |||
Z(χ2)值 | -3.262 | -3.752 | -4.258 | -3.437 | -1.404 | -1.073 | |||
P值 | 0.001 | <0.001 | <0.001 | 0.001 | 0.160 | 0.283 | |||
组别 | 钾〔M(P25,P75),mmol/L〕 | 凝血酶原时间〔M(P25,P75),s〕 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 单核细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | NMLR〔M(P25,P75)〕 | |||
生存组 | 3.95(3.57,4.52) | 13.00(11.90,14.30) | 5.52(4.11,7.95) | 0.40(0.37,0.57) | 1.18(0.79,1.66) | 5.00(3.23,8.72) | |||
死亡组 | 4.10(3.75,4.41) | 12.90(12.60,16.35) | 6.17(4.34,6.82) | 0.44(0.34,0.62) | 0.89(0.73,1.73) | 8.36(3.15,9.55) | |||
Z(χ2)值 | -0.933 | -1.641 | -2.860 | -1.369 | -2.005 | -3.089 | |||
P值 | 0.351 | 0.101 | 0.004 | <0.001 | 0.045 | 0.002 |
项目 | 单因素分析 | 多因素分析 | ||
---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | |
感染 | 2.614(1.020,6.698) | 0.045 | 1.133(0.760,1.690) | 0.539 |
糖尿病 | 2.003(0.789,5.080) | 0.144 | ||
肺循环障碍 | 6.326(2.460,12.267) | <0.001 | 0.954(0.544,1.672) | 0.869 |
周围血管病 | 3.346(1.177,9.515) | 0.023 | 0.958(0.571,1.608) | 0.872 |
脑血管病 | 2.305(0.918,5.786) | 0.075 | ||
肾衰竭 | 3.766(1.514,9.370) | 0.004 | 0.937(0.577,1.522) | 0.794 |
心率 | 1.026(1.006,1.047) | 0.013 | 0.995(0.986,1.004) | 0.306 |
呼吸频率 | 1.039(0.993,1.087) | 0.097 | ||
血红蛋白 | 0.969(0.955,0.93) | <0.001 | 0.993(0.986,1.000) | 0.042 |
阴离子间隙 | 1.246(1.143,1.358) | <0.001 | 1.062(1.009,1.118) | 0.021 |
尿素氮 | 1.094(1.060,1.129) | <0.001 | 1.011(0.985,1.036) | 0.413 |
肌酐 | 1.000(1.000,1.001) | 0.318 | ||
中性粒细胞 | 1.034(1.009,1.059) | 0.007 | 1.098(1.031,1.170) | 0.004 |
单核细胞 | 1.342(1.125,1.602) | 0.001 | 1.338(1.092,1.639) | 0.005 |
淋巴细胞 | 0.578(0.435,0.768) | <0.001 | 0.560(0.410,0.765) | <0.001 |
NMLR | 1.026(1.007,1.046) | 0.008 | 1.003(1.001,1.005) | 0.028 |
Table 2 Univariate and multivariate Cox analysis of influencing factors of in-hospital mortality in patients with HF
项目 | 单因素分析 | 多因素分析 | ||
---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | |
感染 | 2.614(1.020,6.698) | 0.045 | 1.133(0.760,1.690) | 0.539 |
糖尿病 | 2.003(0.789,5.080) | 0.144 | ||
肺循环障碍 | 6.326(2.460,12.267) | <0.001 | 0.954(0.544,1.672) | 0.869 |
周围血管病 | 3.346(1.177,9.515) | 0.023 | 0.958(0.571,1.608) | 0.872 |
脑血管病 | 2.305(0.918,5.786) | 0.075 | ||
肾衰竭 | 3.766(1.514,9.370) | 0.004 | 0.937(0.577,1.522) | 0.794 |
心率 | 1.026(1.006,1.047) | 0.013 | 0.995(0.986,1.004) | 0.306 |
呼吸频率 | 1.039(0.993,1.087) | 0.097 | ||
血红蛋白 | 0.969(0.955,0.93) | <0.001 | 0.993(0.986,1.000) | 0.042 |
阴离子间隙 | 1.246(1.143,1.358) | <0.001 | 1.062(1.009,1.118) | 0.021 |
尿素氮 | 1.094(1.060,1.129) | <0.001 | 1.011(0.985,1.036) | 0.413 |
肌酐 | 1.000(1.000,1.001) | 0.318 | ||
中性粒细胞 | 1.034(1.009,1.059) | 0.007 | 1.098(1.031,1.170) | 0.004 |
单核细胞 | 1.342(1.125,1.602) | 0.001 | 1.338(1.092,1.639) | 0.005 |
淋巴细胞 | 0.578(0.435,0.768) | <0.001 | 0.560(0.410,0.765) | <0.001 |
NMLR | 1.026(1.007,1.046) | 0.008 | 1.003(1.001,1.005) | 0.028 |
变量 | 灵敏度 | 特异度 | 约登指数 | 最佳截断值 | P值 | AUC | 95%CI |
---|---|---|---|---|---|---|---|
NMLR | 0.508 | 0.820 | 0.328 | 7.93 | <0.001 | 0.704 | (0.652,0.757) |
单核细胞计数 | 0.234 | 0.932 | 0.166 | 0.76×109/L | 0.003 | 0.585 | (0.525,0.646) |
中性粒细胞计数 | 0.492 | 0.719 | 0.211 | 6.15×109/L | <0.001 | 0.620 | (0.563,0.676) |
淋巴细胞计数 | 0.002 | 0.999 | 0.001 | 8.93×109/L | <0.001 | 0.341 | (0.289,0.393) |
Table 3 The predictive value of blood cell count indexes for predicting in-hospital mortality in patients with HF
变量 | 灵敏度 | 特异度 | 约登指数 | 最佳截断值 | P值 | AUC | 95%CI |
---|---|---|---|---|---|---|---|
NMLR | 0.508 | 0.820 | 0.328 | 7.93 | <0.001 | 0.704 | (0.652,0.757) |
单核细胞计数 | 0.234 | 0.932 | 0.166 | 0.76×109/L | 0.003 | 0.585 | (0.525,0.646) |
中性粒细胞计数 | 0.492 | 0.719 | 0.211 | 6.15×109/L | <0.001 | 0.620 | (0.563,0.676) |
淋巴细胞计数 | 0.002 | 0.999 | 0.001 | 8.93×109/L | <0.001 | 0.341 | (0.289,0.393) |
[1] |
Writing Committee Members,ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure[J]. J Card Fail,2022,28(5):e1-167. DOI:10.1016/j.cardfail.2022.02.010.
|
[2] |
王华,李莹莹.慢性心力衰竭加重患者的综合管理中国专家共识2022[J].中国循环杂志,2022,37(3):215-225.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):760-789. DOI:10.3760/cma.j.issn.0253-3758.2018.10.004.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
唐超,雍莉,刘火五沙,等. 中性粒细胞与淋巴细胞比值与心力衰竭合并心房颤动患者疾病严重程度相关性分析[J]. 临床急诊杂志,2018,19(5):283-287. DOI:10.13201/j.issn.1009-5918.2018.05.002.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
[1] | MA Shuangshuang, XING Yanjiang, ZHANG Jiawei, WANG Jing. Research Progress on Cardiac Energy Metabolic Changes in Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2025, 28(30): 3831-3840. |
[2] | LIU Zhenyu, WEI Yunpeng, WANG Jiangmin, XING Yan. Causal Association Study between Sleep Duration and Heart Failure [J]. Chinese General Practice, 2025, 28(27): 3441-3446. |
[3] | SHANG Zhonghua, JIANG Zhiyue, HUANG Zhaohui, YANG Xing, LIU Haiyan, ZHANG Li. Trends in Cervical Cancer Burden in China from 1990 to 2021 and Prediction for 2022 to 2035 [J]. Chinese General Practice, 2025, 28(26): 3314-3320. |
[4] | LUO Xinyu, LIU Jin, CHEN Hailong. Trend Analysis of the Changing Disease Burden of Pancreatitis in China and Worldwide from 1990 to 2021 and Prediction for 2022 to 2031 [J]. Chinese General Practice, 2025, 28(26): 3321-3327. |
[5] | LIU Wenjie, SUN Huang, LUO Wei, CHEN Xuan, PENG Yunzhu, LI Ruijie, MA Mier. Wearable Acoustic-electrocardiographic Remote Monitoring Device for Heart Failure [J]. Chinese General Practice, 2025, 28(25): 3104-3109. |
[6] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[7] | HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling. Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction [J]. Chinese General Practice, 2025, 28(24): 2979-2984. |
[8] | SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, MA Qing. Association between Body Mass Index and Mortality among Older Chinese: a Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2791-2797. |
[9] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[10] | HE Ting, LI Jia, TAN Wenbin. Research Progress of Circulatory System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2101-2112. |
[11] | LI Qiujing, SHANG Na, GAO Qian, YANG Li, GUO Shubin. Predictive Value of Abdominal CT Based-skeletal Muscle Mass Combined with Critical Illness Score for Prognosis in Older Patients with Intra-abdominal Sepsis [J]. Chinese General Practice, 2025, 28(12): 1459-1464. |
[12] | HUANG Chuanying, LIAO Xiaoyang, YANG Rong, LI Dongze, ZHANG Peng, JIA Yu, LIU Lidi. Interpretation of the Clinical Statement for Management of Female Cardiac Emergencies in 2024 [J]. Chinese General Practice, 2025, 28(12): 1427-1432. |
[13] | BAI Lu, ZHANG Qiang, LIU Fangfang, SUN Caihong, FEI Sijie, XIN Caifeng. Correlation between Triglyceride Glucose Index and Atrial Fibrillation in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2025, 28(06): 720-728. |
[14] | ZHU Lu, AI Jun, LIAO Shengwu, HUANG Shuting, GONG Nirong, KONG Yaozhong, LIU Dehui, DOU Xianrui, ZHANG Guangqing. Association of Prognostic Nutritional Index with Cardiovascular Mortality in Patients with Peritoneal Dialysis: a Multicenter Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(05): 568-574. |
[15] | LAI Fengxia, WANG Shihong, ZHAO Le, HUANG Ruixian, YANG Zihua, ZHANG Zhiyi, KONG Danli, DING Yuanlin. Analysis and Prediction of Incidence and Mortality Trends of Three Enteric Infectious Diseases in China from 1990 to 2019 [J]. Chinese General Practice, 2025, 28(03): 313-319. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||